-- Bayer's Eylea gets approval in Japan for DME 
-- By Georgina Prodhan
-- Tue Nov 18, 2014 03:15AM EST
-- None



FRANKFURT, Nov 18 (Reuters) - Bayer's <BAYG.DE> Eylea treatment has been approved in Japan for the treatment of diabetes-related visual impairment (DME), Germany's largest drugmaker said on Tuesday.

